Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year.
Baidu Set To Gain From Digital Transformation & ADAS Leadership, Analysts Say
Mizuho analyst James Lee maintained Baidu Inc (NASDAQ:BIDU) with a Buy and lowered the price target from $200 to $180. Baidu Core…